Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Hanwha Aerospace has disclosed a correction extending the confidentiality deferral period for a material supply contract exceeding 2.5% of its recent annual revenue from December 31, 2024, to April 30, 2025.
📊 [Key Disclosure Contents & Major Financial Figures]
1. Correction Overview and Reason
- Target Document: Supply Contract (Originally filed on September 05, 2024)
- Reason for Revision: Extension of disclosure deferral period
2. Key Revised Items (Before Revision → After Revision)
- Expiration Date of Deferral: December 31, 2024 → April 30, 2025
3. Key Terms of Contract & Deferral (Maintained)
- Contract Type: Product Supply
- Contract Date & Start Date: September 04, 2024
- Recent Annual Revenue: KRW 9,359,005,981,309 (Approx. KRW 9.36T, 2023 consolidated revenue)
- Contract Scale Threshold: Exceeds 2.5% of recent annual revenue (Triggering mandatory disclosure requirements)
- Reason for Deferral: Business confidentiality
- Redacted Items: Contract name, contract amount, contract partner, supply region, end date, and payment terms (All key terms redacted)
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verification of Full Terms Upon Extended Deferral Expiration (April 30, 2025)
This disclosure updates the expiration date for withholding details on a major supply contract to April 30, 2025, under trade secrecy provisions. Monitoring the release of the updated disclosure upon or prior to the extended expiration date to confirm the finalized contract amount, counterparty, and delivery terms is important for verifying the financial details. Finalized terms can be verified in future amendment disclosures following the end of the extended deferral period.
📢 Disclaimer and Source Notice
Source: This content was newly generated and structured based on official data filed with the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).
Investment Risk Warning: This material is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific securities. All investment decisions and financial responsibilities rest entirely with the investor.
Inquiries: For compliance inquiries or copyright-related requests, please contact ksb220805@gmail.com.
